The book should therefore prove to be interesting reading and even a bookshelf staple for anyone with an interest in intellectual property in the life sciences.
An excellent book providing guidance on the intellectual property issues affecting the life science sector.
This publication is clearly written and would be a valuable resource to a practitioner in the field.
A unique and fascinating feature of this compact and accessible book lies in how it provides comparative insights, across all those jurisdictions, into many of the “hot topics” that are attracting interest in the field, highlighting the diversity of approach that the same issue can attract.
Intellectual Property in the Life Sciences: A Global Guide to Rights and Their Applications, 2nd Ed provides crucial guidance on all major IP issues affecting the life sciences sector. It uniquely satisfies two practical needs: a global reach that reflects the worldwide markets within which the life sciences industry now operates and a sector-based approach addressing the issues that those in the business face.
Brought fully up to date by world-leading specialists in the field, it provides an overview of the key international and European IP legislation, complementing the book’s central theme of monopoly protection. In addition, the book now features coverage from 20 jurisdictions of the most important and topical life sciences issues on which intellectual property has an impact. Subjects explored within the national chapters include small molecules, secondary patents, DNA and biologicals, patent infringement and enforcement, compulsory licensing, branding and designs, counterfeiting and know-how protection, and patenting and supplementary protection certificates (SPCs) in personalised medicine.
New to the second edition are three standalone chapters providing enhanced coverage on the EU Trade Secrets Directive, SPCs and latest developments concerning the Unitary Patent Court.
This new guide is essential reading for lawyers, in-house counsel and other professionals advising firms in the life sciences industry.